These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8877478)

  • 1. Reduction of etoposide induced cell killing by hyperthermia can occur without changes in etoposide transport or DNA topoisomerase II activity.
    Ng CE; Bussey AM; Raaphorst GP
    Int J Hyperthermia; 1996; 12(4):551-67. PubMed ID: 8877478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence of treatment is important in the modification of camptothecin induced cell killing by hyperthermia.
    Ng CE; Bussey AM; Raaphorst GP
    Int J Hyperthermia; 1996; 12(5):663-78; discussion 679-80. PubMed ID: 8886892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
    Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
    Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermia can reduce cytotoxicity from etoposide without a corresponding reduction in the number of topoisomerase II-DNA cleavable complexes.
    Dynlacht JR; Wong RS; Albright N; Dewey WC
    Cancer Res; 1994 Aug; 54(15):4129-37. PubMed ID: 8033146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines.
    Ng CE; Bussey AM; Raaphorst GP
    Int J Radiat Biol; 1994 Jul; 66(1):49-57. PubMed ID: 8027612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomodulation by hyperthermia of topoisomerase II-targeting drugs in human colorectal cancer cells.
    Hirohashi Y; Hidaka K; Sato S; Kuwano M; Kohno K; Hisatsugu T
    Jpn J Cancer Res; 1995 Nov; 86(11):1097-105. PubMed ID: 8567402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations.
    Suzuki H; Tarumoto Y; Ohsawa M
    Mutagenesis; 1997 Jan; 12(1):29-33. PubMed ID: 9025094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerase I content of a pair of human melanoma cell lines with very different radiosensitivities correlates with their in vitro sensitivities to camptothecin.
    Ng CE; Cybulski SE; Bussey AM; Aubin RA; Raaphorst GP
    Anticancer Res; 1998; 18(4C):3119-26. PubMed ID: 9713520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene.
    Lorico A; Rappa G; Srimatkandada S; Catapano CV; Fernandes DJ; Germino JF; Sartorelli AC
    Cancer Res; 1995 Oct; 55(19):4352-60. PubMed ID: 7671247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
    Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M
    Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity studies of novobiocin analogs as modulators of the cytotoxicity of etoposide (VP-16).
    Rappa G; Shyam K; Lorico A; Fodstad O; Sartorelli AC
    Oncol Res; 2000; 12(3):113-9. PubMed ID: 11216669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermic modulation of SN-38-induced topoisomerase I DNA cross-linking and SN-38 cytotoxicity through altered topoisomerase I activity.
    Katschinski DM; Robins HI
    Int J Cancer; 1999 Jan; 80(1):104-9. PubMed ID: 9935239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.
    Ganapathi R; Constantinou A; Kamath N; Dubyak G; Grabowski D; Krivacic K
    Mol Pharmacol; 1996 Aug; 50(2):243-8. PubMed ID: 8700130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation.
    Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T
    Jpn J Cancer Res; 2001 Jul; 92(7):799-805. PubMed ID: 11473732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic cytotoxicity of topoisomerase I inhibitors with alkylating agents and etoposide in human brain tumor cell lines.
    Janss AJ; Cnaan A; Zhao H; Shpilsky A; Levow C; Sutton L; Phillips PC
    Anticancer Drugs; 1998 Aug; 9(7):641-52. PubMed ID: 9773809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synergetic cytotoxicity of cisplatin and etoposide to leukemia cell line K562 and its mechanism].
    Ma WD; Yin MY; Jiang CW; Xu SR; Zhai LD; Zheng LF; Wang YL; Yan YL
    Ai Zheng; 2005 Aug; 24(8):958-64. PubMed ID: 16086873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modalities of resistance in etoposide-resistant human KB cell lines.
    Ferguson PJ; Fisher MH; Stephenson J; Li DH; Zhou BS; Cheng YC
    Cancer Res; 1988 Nov; 48(21):5956-64. PubMed ID: 2844393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
    Ritke MK; Murray NR; Allan WP; Fields AP; Yalowich JC
    Mol Pharmacol; 1995 Nov; 48(5):798-805. PubMed ID: 7476909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.
    Reuveni D; Halperin D; Shalit I; Priel E; Fabian I
    Int J Oncol; 2010 Aug; 37(2):463-71. PubMed ID: 20596674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.